Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
35,528
Total Claims
$1.3M
Drug Cost
1,281
Beneficiaries
$997
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-94%
Opioid rate vs peers
0.1% vs 2.5% avg
-12%
Cost per patient vs peers
$997 vs $1,128 avg
+1%
Brand preference vs peers
8.5% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
51
Opioid Claims
$219
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,960 claims · $933K
Generic: 32,011 claims · $331K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Nph Hum/Reg Insulin Hm | 331 | $113K |
| Sitagliptin Phos/Metformin Hcl | 110 | $81K |
| Insulin Glargine,hum.Rec.Anlog | 149 | $80K |
| Apixaban | 107 | $63K |
| Linagliptin/Metformin Hcl | 83 | $55K |
| Dapagliflozin Propanediol | 79 | $52K |
| Insulin Regular, Human | 116 | $35K |
| Insulin Nph Human Isophane | 77 | $31K |
| Insulin Lispro | 56 | $31K |
| Rivaroxaban | 49 | $29K |
| Empagliflozin | 39 | $26K |
| Sitagliptin Phosphate | 38 | $25K |
| Ticagrelor | 52 | $24K |
| Losartan Potassium | 1,622 | $20K |
| Dapaglifloz Propaned/Metformin | 35 | $20K |
Prescribing Profile
Patient Profile
74
Avg Age
55%
Female
2.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data